NUMELVI is a tablet taken once daily, and it is the first treatment and the only second-generation Janus kinase (JAK) inhibitor recommended for treating itch associated with allergic dermatitis, including atopic dermatitis, and for treating the clinical symptoms of atopic dermatitis in dogs. NUMELVI – the next generation of itch relief – is a new product for managing allergic dermatitis in dogs, offering selectivity, safety, and ease. Active Ingredients NUMELVI contains Atinvetitinib. Indications For the treatment of itch associated with allergic dermatitis, including atopic dermatitis in dogs. For the treatment of inflammation and clinical symptoms of atopic dermatitis in dogs.
Expires on February 28, 2029